VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
INNV
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
INNVInnovAge Holding Corp.
$8.91$1.2B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
INNV logo

InnovAge Holding Corp.

INNV
NASDAQ · Healthcare Providers
$8.91
At close - Nov 18, 4:00 PM EST - USD
Market Cap$1.21B
P/E135.8x
52W High$12.64
Volume523.18K
OverviewTerminalAnalysisFinancialsValuationEarningsBreakoutsOwnership
VCP Research Verdict2027Q1

Revenue Recovery Meets Thin Margins and Fragile Liquidity

InnovAge's top line is re-accelerating, with revenue growing 12.1% year over year to $264.8M in the latest quarter, and gross margin recovering to 21.9% from a trough near 16.8%, which suggests improving spread between capitated revenue and medical costs.

GrowthExpanding
ProfitabilityModerate
ValuationExpensive
TechnicalsWeak
Explore valuation models
MARKET ACTION

INNV price & volume

Price trend, volume and key moving averages

Launch Terminal
Loading chart...
Decision Checklist4 Core Signals

What matters now

The signals most likely to change the investment case.

01

Earnings momentum

5/12 Beats

EPS beat 5 of last 12 quarters

02

Valuation risk

+392% Peers

P/E is 392% above peer median

03

Market leadership

RS 80 · Leader

High momentum (Outperforming 80% of market)

04

Weak Trend

Below 200DMA

Price < 200DMA

Next CatalystEstimated earnings · Feb 3

Market performance

Price History →

Trailing total returns as of 11/19/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).

YTD Return
INNV+71.68%
S&P 500 (^GSPC)+6.88%
1-Year Return
INNV+59.39%
S&P 500 (^GSPC)+10.62%
3-Year Return
INNV+53.62%
S&P 500 (^GSPC)+49.86%
5-Year Return
INNV+4.82%
S&P 500 (^GSPC)+53.42%
02

Test the fundamentals

Check whether operating performance supports the current valuation.

VALUATION & INTRINSIC VALUE

Valuation Scenarios

Valuation Analysis
Trailing P/E
135.8x
Forward P/E
N/A
EV/EBITDA0th %ile
12.4x
FCF YieldCash Flow
6.3%

Valuation vs 5-Year History

Multiple Range
Metric
Current
5Y Median
Historical Range
Percentile
P/E
135.8x
N/A
N/A
EV/EBITDA
12.4x
51.9x
0th· Low
Price/FCF
15.8x
31.9x
0th· Low
Current Multiple
5Y Median (50th %ile)

Intrinsic Value Scenarios

DCF Projection
Bear$1.73-80.6%
Base (Fair)$3.78-60.1%
Bull$5.34-40.1%
$1.73 Bear$3.78 Base$5.34 Bull
Current Market Price: $8.91
Trades at a 135.7% premium to Base DCF ($3.78)
Open DCF & Valuation Models →Chart Terminal ↗

Growth & profitability

Annual revenue & EPS trend
Revenue FY26
$990M+15.9% YoY
Net income FY26
-$3M+91.6% YoY
Free cash flow FY26
$50M+89.5% YoY
Operating margin FY26
6.7%+10.2 pts YoY
ROIC (FY26)17.8%
Avg ROIC 5Y-1.5%
ROE (TTM)3.3%
Piotroski Score5 / 9
Financial Statements →
03

Monitor what changed

Recent results and news deserve attention only when they alter the forward view.

OPERATING RESULTS

Recent Earnings

Earnings History
EPS Beat Rate5/12 (42%)
Revenue Beat Rate11/12 (92%)
QuarterEPS (Act vs Est)Revenue (Act vs Est)
Q4 2026Latest
Nov 3, 2026
$0.14+62.9%
vs $0.09
$265M+2.9%
vs $257M
Q4 2026
Sep 8, 2026
$0.06-19.6%
vs $0.07
$262M+9.9%
vs $238M
Q2 2026
May 5, 2026
-$0.22-466.7%
vs $0.06
$252M+7.5%
vs $234M
Q1 2026
Feb 3, 2026
$0.08+100.0%
vs $0.04
$240M+5.0%
vs $228M
Historical baseline: 12 quarters analyzedGAAP / Adjusted
MARKET COVERAGE

Latest News

4 Stories
Seeking Alpha·Nov 4, 2026
InnovAge Holding Corp. (INNV) Q1 2027 Earnings Call Transcript

InnovAge Holding Corp. ( INNV ) Q1 2027 Earnings Call November 3, 2026 5:00 PM EST Company Participants Ryan Kubota - Director of Investor Relations Patrick Blair - Chief Executive Officer Benjamin Adams - Chief Financial Officer Conference Call Participants Benjamin Rossi - JPMorgan Chase & Co, Research Division Matthew Gillmor - KeyBanc Capital Markets Inc., Research Division Jared Haase - William Blair & Company L.L.C., Research Division Presentation Operator Good day, and thank you for standing by.

Zacks Investment Research·Nov 3, 2026
InnovAge Holding Corp. (INNV) Tops Q1 Earnings and Revenue Estimates

InnovAge Holding Corp. (INNV) came out with quarterly earnings of $0.14 per share, beating the Zacks Consensus Estimate of $0.11 per share. This compares to earnings of $0.06 per share a year ago.

MarketBeat·Nov 3, 2026
What InnovAge (INNV) Said on Its Q1 Earnings Call

InnovAge NASDAQ: INNV reported fiscal first-quarter 2027 revenue of $264.8 million, up 12.1% from a year earlier, as participant growth and higher capitation rates contributed to gains. The company also posted net income of $20.9 million, compared with $7.7 million in the prior-year quarter, while adjusted EBITDA rose to $31.3 million from $17.6 million.

GlobeNewsWire·Nov 3, 2026
InnovAge Announces Financial Results for the Fiscal First Quarter Ended September 30, 2026

DENVER, Nov. 03, 2026 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), today announced financial results for its fiscal first quarter ended September 30, 2026. “We are pleased with our strong stat to fiscal 2027, as continued census growth along with disciplined clinical and operational execution drove strong financial performance,” said Patrick Blair, Chief Executive Officer of InnovAge.

Filtered for InnovAge Holding Corp.More Headlines
04

Compare before deciding

Benchmark INNV against direct peers instead of judging its metrics in isolation.

Peers Comparison

Key metrics vs top competitors for InnovAge Holding Corp. (INNV)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
INNV logoINNVInnovAge Holding Corp.Current
$8.91$1.21B135.8215.93%0.88%3.25%—
ALHC logoALHCAlignment Healthcare, Inc.
$6.72$1.39B48.4546.06%0.59%12.46%—
OSCR logoOSCROscar Health, Inc.
$27.57$7.15B11.1727.5%4.9%49.39%—
ENSG logoENSGThe Ensign Group, Inc.
$182.98$10.66B27.1918.72%7.03%16.61%0.13%
UNH logoUNHUnitedHealth Group Incorporated
$349.91$317.77B19.8711.81%3.53%15.18%2.49%
HUM logoHUMHumana Inc.
$385.71$46.31B37.7410.06%0.81%6.68%0.92%

Compare INNV vs Peers

InnovAge Holding Corp. (INNV) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs ALHC

Most directly comparable listed peer for INNV.

Scale Benchmark

vs UNH

Larger-name benchmark to compare INNV against a more recognizable public peer.

Peer Set

Compare Top 5

vs ALHC, OSCR, ENSG, UNH

05

Keep researching

Verify the primary filings, follow material updates, and answer the remaining questions.

INNV SEC Filings & Documents

InnovAge Holding Corp. (INNV) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Nov 3, 2026·SEC

Material company update

Sep 8, 2026·SEC

Material company update

May 5, 2026·SEC

10-K Annual Reports

4
FY 2026

Sep 9, 2026·SEC

FY 2025

Sep 9, 2025·SEC

FY 2024

Sep 10, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

Nov 3, 2026·SEC

FY 2026

Feb 3, 2026·SEC

FY 2025

Nov 4, 2025·SEC

Get notified when INNV posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

INNV Frequently Asked Questions

InnovAge Holding Corp. (INNV) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is InnovAge Holding Corp.'s revenue?

InnovAge Holding Corp. (INNV) reported $1.02B in revenue over the trailing twelve months. Revenue was $989.7M in fiscal year 2026. That is 113% more than the $465.6M of fiscal year 2019.

How fast is InnovAge Holding Corp. growing?

InnovAge Holding Corp. (INNV) grew revenue by 15.5% over the trailing twelve months, compared with the twelve months before.

Is INNV profitable?

Yes. InnovAge Holding Corp. (INNV) earned $9.0M in net income over the trailing twelve months (a 0.9% net margin).

Dividend & Returns
What is INNV's return on equity?

InnovAge Holding Corp. (INNV) had a return on equity (ROE) of 3.3% over the trailing twelve months. That is below the market's typical 10-15%.

What is InnovAge Holding Corp.'s free cash flow?

InnovAge Holding Corp. (INNV) generated $76.4M in free cash flow over the trailing twelve months.

What if you invested $1,000 in INNV back in 2019?

Total return calculator · dividends reinvested · 7+ years of data

See returns →